This inventor holds 1 USPTO granted patent. Top assignee: The Wistar Institute. Active years: 2007.
Company Filing History:
Years Active: 2007
Title: Linda B Schultz: A Pioneer in DNA Damage Detection
Introduction
Linda B Schultz, an accomplished inventor based in Suwanee, Georgia, has made significant strides in the field of cancer research. With one patent to her name, Schultz is recognized for her innovative methods in detecting DNA damage, an area crucial for developing cancer therapeutics.
Latest Patents
Schultz's patent, titled "Methods for detecting DNA damage and screening for cancer therapeutics," outlines a novel method for identifying DNA damage in tissue samples. This technique involves the use of an immobilized biological sample that is contacted with a labeled ligand capable of binding to human 53Bp1. By examining the immobilized sample for a detectable signal concentrated in foci, the presence of DNA damage can be indicated, while a diffuse signal suggests a normal sample. The patent also describes diagnostic reagents and kits that facilitate the detection of DNA damage, along with compositions that inhibit or antagonize the biological activity of 53Bp1 to potentially retard cancer cell growth.
Career Highlights
Linda B Schultz's career is highlighted by her work at the Wistar Institute of Anatomy & Biology, where she has contributed significantly to the advancement of molecular biology and cancer research. Her dedication to scientific inquiry and innovation has established her as a respected member of the research community.
Collaborations
Throughout her career, Schultz has collaborated with esteemed colleagues, including Thanos D Halazonetis. These partnerships have further strengthened her research and contributed to significant findings in the understanding of DNA damage and its implications for cancer therapeutics.
Conclusion
Linda B Schultz stands out as a vital contributor to the field of cancer research through her inventive methodologies for detecting DNA damage. Her patent represents a step forward in the development of diagnostic tools and therapeutic strategies, underscoring her impact on both scientific research and clinical applications.